# An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Cancer Participants With Inadequately Controlled Pain by Non-Narcotic Analgesics

> **NCT01060124** · PHASE4 · COMPLETED · sponsor: **Janssen Korea, Ltd., Korea** · enrollment: 103 (actual)

## Conditions studied

- Pain; Cancer

## Interventions

- **DRUG:** Fentanyl D-trans

## Key facts

- **NCT ID:** NCT01060124
- **Lead sponsor:** Janssen Korea, Ltd., Korea
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2014-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01060124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01060124, "An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Cancer Participants With Inadequately Controlled Pain by Non-Narcotic Analgesics". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01060124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*